A randomized, four-way crossover, comparative bio-availability study of branded (Neurontin) and three generic 800 mg gabapentin tablets in healthy subjects under fasting conditions
Phase of Trial: Phase I
Latest Information Update: 02 Jan 2018
At a glance
- Drugs Gabapentin (Primary)
- Indications Epilepsy
- Focus Pharmacokinetics
- 31 Aug 2013 Results presented at the 11th Congress of the European Association for Clinical Pharmacology and Therapeutics.
- 31 Aug 2013 Primary endpoint 'Peak-drug-concentration' has been met.
- 31 Aug 2013 Primary endpoint 'Area-under-the-drug-concentration-time-curve' has been met.